"10.1371_journal.pone.0065519","plos one","2013-06-06T00:00:00Z","Mahesh Jonnalagadda; Christine E Brown; Wen-Chung Chang; Julie R Ostberg; Stephen J Forman; Michael C Jensen","Departments of Cancer Immunotherapeutics & Tumor Immunology, and Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope, Duarte, California, United States of America; Ben Towne Center for Childhood Cancer Research, Seattle Childrens Research Institute, Seattle, Washington, United States of America","Conceived and designed the experiments: MJ CEB MCJ. Performed the experiments: MJ. Analyzed the data: MJ CEB WCC JRO SJF MCJ. Contributed reagents/materials/analysis tools: MJ. Wrote the paper: MJ.","MCJ is an inventor of licensed patents and equity holder in ZetaRx, Inc., a licensee of these patents. Patent application number: 20090324630, FUSION MULTIVIRAL CHIMERIC ANTIGEN and Patent application number: 20120148552, METHOD AND COMPOSITIONS FOR ENHANCED ANTI-TUMOR EFFECTOR FUNCTIONING OF T CELLS. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","06","Mahesh Jonnalagadda","MJ",6,TRUE,3,1,6,1,TRUE,TRUE,FALSE,0,NA,FALSE
